Immuneering Financial Overview
Immuneering's market cap is currently $370.63M. The company's EPS TTM is $-0.38; its P/E ratio is -3.08; Immuneering is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
